Dale Zajicek

BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada.

Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX.

Oncolix, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of medical therapies for the treatment of various cancers including ovarian, breast, uterine, and prostate. Its brand Prolanta is a drug designed to block the effect of human prolactin in cancers, either as a stand-alone therapy or in combination with other drugs, by blocking the effect of human prolactin. The company was founded on June 2013 and is headquartered in Houston, TX.